NCT04125888View on ClinicalTrials.gov

Impact of AIT on Allergic Rhinitis and Asthma

CompletedOBSERVATIONAL
Enrollment

92,048

Participants

Timeline

Start Date

July 22, 2019

Primary Completion Date

April 16, 2021

Study Completion Date

April 16, 2021

Conditions
AllergyRespiratory Disease
Interventions
DRUG

Allergy immunotherapy (AIT)

Immunotherapy for different types of allergies

Trial Locations (1)

DK-2970

ALK Abelló, Hørsholm

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT04125888 - Impact of AIT on Allergic Rhinitis and Asthma | Biotech Hunter | Biotech Hunter